Prospective study of oral contraceptives and hypertension among women in the United States.
暂无分享,去创建一个
J. Manson | W. Willett | D. Spiegelman | D. Hunter | M. Stampfer | G. Curhan | G. Colditz | L. Chasan-Taber | M. Stampfer | W. Willett | D. Hunter | G. Colditz
[1] G A Colditz,et al. Reproducibility and validity of a self-administered physical activity questionnaire. , 1994, International journal of epidemiology.
[2] R. Dickey. Managing Contraceptive Pill Patients , 1994 .
[3] R B D'Agostino,et al. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. , 1990, Statistics in medicine.
[4] W. Willett,et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. , 1986, American journal of epidemiology.
[5] T. Ezzati,et al. Prevalence and trends in oral contraceptive use in premenopausal females ages 12-54 years, United States, 1971-80. , 1985, American journal of public health.
[6] L. Dorflinger. Relative potency of progestins used in oral contraceptives. , 1985, Contraception.
[7] J. Cruickshank,et al. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen , 1984, British journal of obstetrics and gynaecology.
[8] B Rosner,et al. Predictive values of routine blood pressure measurements in screening for hypertension. , 1983, American journal of epidemiology.
[9] K. Khaw,et al. Blood pressure and contraceptive use , 1982, British medical journal.
[10] Weir Rj. Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension. , 1982 .
[11] U. Gaspard,et al. Clinical experience with triphasic oral contraceptives (TrigynonR) in six hundred cycles , 1982 .
[12] G. Zador. Clinical performance of a triphasic administration of ethinyl estradiol and levonorgestrel in comparison with the 30 + 150μg fixed-dose regime , 1982 .
[13] W. Hall,et al. Blood pressure changes and oral contraceptive use: a study of 2676 black women in the southeastern United States. , 1980, American journal of epidemiology.
[14] B. Bloch. The effect of cyclical administration of levonorgestrel and ethinyloestradiol on blood pressure, body mass, blood glucose and serum triglycerides. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[15] M. Briggs,et al. ŒSTROGEN CONTENT OF ORAL CONTRACEPTIVES , 1977, The Lancet.
[16] T. Meade,et al. HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGEN , 1977, The Lancet.
[17] W. Barclay. AMA drug evaluations. , 1977, JAMA.
[18] I. Fisch,et al. Oral contraceptives and blood pressure. , 1977, JAMA.
[19] O. Miettinen,et al. Estimability and estimation in case-referent studies. , 1976, American journal of epidemiology.
[20] R. Weir,et al. Blood Pressure in Women Taking Oral Contraceptives , 1974, American heart journal.
[21] V. Beral. ORAL CONTRACEPTIVES AND HEALTH , 1974 .
[22] O S Miettinen,et al. Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.
[23] J. Woods. Oral Contraceptives and Hypertension , 1988, Lancet.